Gyre Therapeutics (GYRE) Interest Coverage Ratio (2010 - 2024)
Gyre Therapeutics (GYRE) reported Interest Coverage Ratio of 25.62 for Q1 2024, up 147.23% year-over-year from 10.36 in Q2 2023, and up 147.23% on a QoQ basis from 10.36 in Q1 2023.
Gyre Therapeutics (GYRE) has 10 years of Interest Coverage Ratio data on file, last reported at 25.62 in Q1 2024.
- Quarterly Interest Coverage Ratio rose 147.23% year-over-year to 25.62 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was 51.31 (up 149.07% YoY) and the FY2023 annual result came in at 25.92, down 486.95% from the prior year.
- Interest Coverage Ratio rose to 25.62 in Q1 2024 per GYRE's latest filing, from 10.36 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 25.62 in Q1 2024 and bottomed at 2300.0 in Q3 2020.
- The 3-year median for Interest Coverage Ratio is 127.5 (2020), against an average of 632.35.
- The widest annual swing landed in 2020, when Interest Coverage Ratio slumped 164.51%; it then soared 147.23% in 2024.
- Tracing GYRE's Interest Coverage Ratio over 3 years: stood at 265.37 in 2020, then soared by 103.91% to 10.36 in 2023, then soared by 147.23% to 25.62 in 2024.
- Per Business Quant, the three latest GYRE Interest Coverage Ratio figures stand at 25.62 (Q1 2024), 10.36 (Q1 2023), and 265.37 (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 25.62 |
| Mar 31, 2023 | 10.36 |
| Dec 31, 2020 | -265.37 |
| Sep 30, 2020 | -2,300.00 |
| Dec 31, 2019 | 411.38 |
| Dec 31, 2015 | -3.40 |
| Jun 30, 2015 | -56.44 |
| Dec 31, 2014 | -599.33 |
| Sep 30, 2014 | -327.60 |
| Jun 30, 2014 | -368.33 |
| Mar 31, 2014 | -207.00 |
| Dec 31, 2013 | -1,330.80 |
| Sep 30, 2013 | -1,011.23 |
| Jun 30, 2013 | -892.00 |
| Mar 31, 2013 | -517.13 |
| Dec 31, 2012 | -903.33 |
| Sep 30, 2012 | -404.90 |
| Jun 30, 2012 | 647.00 |
| Mar 31, 2012 | 76.38 |
| Dec 31, 2011 | -307.42 |
| Sep 30, 2011 | -239.26 |
| Jun 30, 2011 | -88.66 |
| Mar 31, 2011 | 396.84 |
| Dec 31, 2010 | -34.79 |
| Sep 30, 2010 | 71.09 |
| Jun 30, 2010 | 130.68 |